Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities

By sjmartinez • February 14, 2025

Pandey A, Alcaraz M Jr, Saggese P, Soto A, Gomez E, Jaldu S, Yanagawa J, Scafoglio C. Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities. Cancers (Basel). 2025 Jan 30;17(3):466. doi: 10.3390/cancers17030466. PMID: 39941833.

Tags: Cancer, glucose, Metabolism, Publications, Pulmonary, Critical Care & Sleep Medicine, SGLT2 inhibitor

Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis

Leslie LA, Baird JH, Flinn IW, Tees M, Hoda D, Deol A, Young P, McClune B, Varadarajan I, Essell J, Fanning S, Simmons G, Clark[...]

Hyperferritinemia as a Clue to Neuroendocrine Carcinoma

Chao ES, Yoshikawa G, Qing X, Huang C. Hyperferritinemia as a Clue to Neuroendocrine Carcinoma. Cureus. 2025 Aug 13;17(8):e90020. doi: 10.7759/cureus.90020. PMID: 40951183; PMCID: PMC12431798.

Identifying Core Clinical Topics and Recommending Core Performance Measures for Internal Medicine Physicians: A Position Paper From the American College of Physicians

Qaseem A, Fitterman N, Tierney S, Powell RE, Campos K, Choi EI, Crandall CJ, Cross JT Jr, Humphrey LL, Obley AJ, Wilt TJ, Andrews RA;[...]